Riverbridge Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.6M | Sell |
|
|||||
|
2025
Q2 | $20.3M | Sell |
|
|||||
|
2025
Q1 | $33.5M | Sell |
|
|||||
|
2024
Q4 | $44.2M | Sell |
|
|||||
|
2024
Q3 | $52.5M | Sell |
|
|||||
|
2024
Q2 | $59.8M | Sell |
|
|||||
|
2024
Q1 | $82.3M | Buy |
|
|||||
|
2023
Q4 | $71.1M | Sell |
|
|||||
|
2023
Q3 | $61.7M | Sell |
|
|||||
|
2023
Q2 | $67.5M | Buy |
|
|||||
|
2023
Q1 | $60.3M | Sell |
|
|||||
|
2022
Q4 | $65.5M | Sell |
|
|||||
|
2022
Q3 | $62.8M | Buy |
|
|||||
|
2022
Q2 | $49.5M | Sell |
|
|||||
|
2022
Q1 | $73.6M | Buy |
|
|||||
|
2021
Q4 | $64.4M | Buy |
|
|||||
|
2021
Q3 | $68.2M | Sell |
|
|||||
|
2021
Q2 | $61.4M | Buy |
|
|||||
|
2021
Q1 | $45M | Buy |
|